Type D personality is associated with delaying patients to medical assessment and poor quality of life among rectal cancer survivors

Zhang, Jia-kui; Fang, Lili; Zhang, Dewei; Qiu, Jin; Wu, Xiaohua; Liu, Ji-chao; Zhang, Chundong; Dai, Dong‐Qiu

doi:10.1007/s00384-015-2333-4

Cited by 17 publications

(7 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of type‐D personality among patients with primary brain tumours was 34.1% in this study. This is higher than the prevalence identified in patients with gastric cancer (23%; Zhang et al, 2016) and colorectal cancer (21.0%; Husson et al, 2017), or in survivors of various types of cancer including endometrial cancer, colorectal cancer, lymphoma and multiple myeloma (19%; Mols et al, 2012). Compared to other patients with chronic disease in the Korean population, the prevalence of type‐D personality in patients with brain tumours was lower than in patients with recurrent coronary artery disease (46.7%; Jo et al, 2019) and patients receiving chemotherapy for ovarian cancer (56.0%; Kim et al, 2018), but higher than in patients with Parkinson's disease (19.9%; Kim et al, 2017a) and end‐stage renal disease (26.0%; Son et al, 2012).…”

Section: Discussionmentioning

confidence: 70%

Type‐D personality and quality of life in patients with primary brain tumours

et al. 2020

View full text Add to dashboard Cite

Objective To investigate the influence of type‐D personality on quality of life (QoL) in patients with primary brain tumours. Methods We performed descriptive cross‐sectional study between July 2018 and March 2019. A convenience sample of 293 patients was recruited from an outpatient neurosurgery clinic. Results Type‐D personality was identified in 34.1% of subjects. Type‐D patients had poorer QoL and experienced more severe symptoms and interference with life. Poor QoL was associated with lower education, no spouse and lower family income. Symptoms were the most significant factor affecting QoL, followed by type‐D personality, income and education. Conclusion Symptoms, type‐D personality and demographic factors should be considered when assessing QoL in patients with primary brain tumours. Interventions that reflect these characteristics, including type‐D personality, may help improve QoL for patients with primary brain tumours.

show abstract

Section: Discussionmentioning

confidence: 70%

Type‐D personality and quality of life in patients with primary brain tumours

et al. 2020

View full text Add to dashboard Cite

show abstract

“…For example, there is evidence of the role of personality characteristics [such as emotional lability, extraversion, openness to experience, agreeableness, conscientiousness (Paika et al, 2010 ), denial and sense of coherence (Hyphantis et al, 2011 ), repression and sense of coherence (Glavić et al, 2014 ) or neuroticism (Ristvedt and Trinkaus, 2005 )] in predicting Quality of Life (QoL) and illness perception (Mols et al, 2012a ; Schoormans et al, 2017 ) after cancer and related treatments. In other studies, Type D Personality and its components (negative affectivity and social inhibition) were associated with all-cause mortality (Shun et al, 2011 ), worse QoL in different domains (Shun et al, 2011 ; Mols et al, 2012b ; Husson et al, 2015 ; Zhang et al, 2016 ) and most disease-specific symptoms (Zhang et al, 2016 ) in CRC patients. Beside the importance of personality in coping with cancer after a diagnosis, this review wants to focus on personality as a contributing risk factor for the incidence of CRC.…”

Section: Introductionmentioning

confidence: 88%

Personality Factors in Colorectal Cancer: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Background: The role of personality in cancer incidence and development has been studied for a long time. As colorectal cancer (CRC) is one of the most prevalent cancer types and linked with lifestyle habits, it is important to better understand its psychological correlates, in order to design a more specific prevention and intervention plan. The aim of this systematic review is to analyze all the studies investigating the role of personality in CRC incidence.Methods: All studies on CRC and personality up to November 2020 were scrutinized according to the Cochrane Collaboration and the PRISMA statements. Selected studies were additionally evaluated for the Risk of Bias according to the Newcastle-Ottawa Scale (NOS).Results: Eight studies met the inclusion criteria and were eventually included in this review. Two main constructs have been identified as potential contributors of CRC incidence: emotional regulation (anger) and relational style (egoism).Conclusion: Strong conclusions regarding the influence of personality traits on the incidence of CRC are not possible, because of the small number and the heterogeneity of the selected studies. Further research is needed to understand the complexity of personality and its role in the incidence of CRC and the interaction with other valuable risk factors.

show abstract

“…Recent evidence has indicated that assessment of health-related quality of life (HR-QoL) may provide valuable information to improve risk assessment in CRC [4]. Evidence-based findings indicate that physical and psychosocial factors other than sociodemographic or clinical variables are associated with increased risk of impaired HR-QoL [5] and may predict CRC survival [6–8]. From a clinical perspective, HR-QoL as complementary data with clinical factors can help to screen for at risk sub-populations with physical or psychosocial issues that may benefit from enhanced monitoring or improved care management.…”

Section: Introductionmentioning

confidence: 99%

Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis

Reyes

Zhou

et al. 2016

Qual Life Res

View full text Add to dashboard Cite

Purpose To investigate the mediators of health-related quality of life (HR-QoL) in colorectal cancer (CRC) patients and effect on overall survival. Methods We analyzed baseline (within 1 year of diagnosis) SF-12v1 questionnaire data from 3,734 CRC patients and assessed the differences in mental composite scores (MCS) and physical composite scores (PCS) by socio-demographics and risks of poor HR-QoL by these factors. Hazard ratios were generated using univariate cox regression for MCS and PCS dichotomized using the normalized scoring based mean of 50 and survival estimates generated using the Kaplan-Meier method. Results Differences in MCS and PCS were identified by sex, age, education level, alcohol use, tobacco use, and stage. Race, marital status, and cancer site differed only by PCS. Being female, never married, former alcohol user, or with stage IV disease significantly increased risk of a poor HR-QoL, with magnitudes of risk from 1.25- to 1.97-fold. Higher education level had a protective effect (MCS: Ptrend=2.32×10−7; PCS: Ptrend=5.62×10−14). Hispanics and African-Americans had a 1.35- and 1.57-fold risk of poor PCS, and increase in age had a protective effect for risk of poor MCS (Ptrend=1.84×10−7). Poor MCS or PCS were associated with poor prognosis and decreased survival at 5-years (HRMCS=1.57, 95%CI=1.41–1.76 and HRPCS=2.38, 95%CI=2.08–2.72), and both remained significant when adjusting for age, gender, race, education level, tumor stage, and tumor site. Conclusions Our findings identify potential mediators for HR-QoL and suggest that baseline HR-QoL assessment may be prognostic for CRC.

show abstract

Type D personality is associated with delaying patients to medical assessment and poor quality of life among rectal cancer survivors

Cited by 17 publications

References 32 publications

Type‐D personality and quality of life in patients with primary brain tumours

Type‐D personality and quality of life in patients with primary brain tumours

Personality Factors in Colorectal Cancer: A Systematic Review

Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis

Contact Info

Product

Resources

About